Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Search
Search for:
The word or phrase you're searching for
Within sections:
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
The sections you wish to include in your search
Search Results
Website Content
(1)
Medicines
(6)
Companies
(0)
Displaying 1 - 1 of 1 results.
Publications & Forms
IMB Newsletter-Issue No. 20-January-June 2005
About Us
Publications & Forms
Newsletters & Reports
Displaying 1 - 6 of 6 results.
Medicine
SANDOSTATIN 100 microgram/1ml, solution for injection/infusion
Medicines
Medicines Information
Find a medicine
Active Substance(s): Octreotide
Strength & Dosage: 100 microgram(s) Solution for injection/infusion
PA0896/028/002
Authorised: 18/11/1988
Novartis Ireland Limited
Medicine
SANDOSTATIN 50 microgram/1 ml, solution for injection/infusion
Medicines
Medicines Information
Find a medicine
Active Substance(s): Octreotide
Strength & Dosage: 50 microgram(s) Solution for injection/infusion
PA0896/028/001
Authorised: 18/11/1988
Novartis Ireland Limited
Medicine
SANDOSTATIN 500 microgram/1 ml, solution for injection/infusion
Medicines
Medicines Information
Find a medicine
Active Substance(s): Octreotide
Strength & Dosage: 500 microgram(s) Solution for injection/infusion
PA0896/028/003
Authorised: 18/11/1988
Novartis Ireland Limited
Medicine
Sandostatin LAR 10 mg powder and solvent for suspension for injection
Medicines
Medicines Information
Find a medicine
Active Substance(s): Octreotide
Strength & Dosage: 10 milligram(s) Powder and solvent for suspension for injection
PA0896/028/004
Authorised: 13/07/1998
Novartis Ireland Limited
Medicine
Sandostatin LAR 20 mg powder and solvent for suspension for injection
Medicines
Medicines Information
Find a medicine
Active Substance(s): Octreotide
Strength & Dosage: 20 milligram(s) Powder and solvent for suspension for injection
PA0896/028/005
Authorised: 13/07/1998
Novartis Ireland Limited
Medicine
Sandostatin LAR 30 mg powder and solvent for suspension for injection
Medicines
Medicines Information
Find a medicine
Active Substance(s): Octreotide
Strength & Dosage: 30 milligram(s) Powder and solvent for suspension for injection
PA0896/028/006
Authorised: 13/07/1998
Novartis Ireland Limited
No records found.
Date Printed: 19/04/2024